Abbott Laboratories (ABT)
How ABT actually reacts to news — the realized, point-in-time move the market made, measured across 431 labeled events over the last three years with zero look-ahead.
ABT’s median reaction, across the day.
Email me when ABT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ABT’s baseline. Nothing else.
Get “How ABT reacts to news” as a PDF.
A free one-page summary: ABT’s median reaction to news and the full breakdown by event type — the numbers on this page, in one page.
Recent ABT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q ABBOTT LABORATORIES For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.48% | +0.96% | |
| Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance | Press release | PR Newswire | +3.71% | +3.63% | |
| Form 8-K ABBOTT LABORATORIES For: Jul 16 | SEC filing · Form 8-K | SEC EDGAR | +3.71% | +3.63% | |
| Abbott hosts conference call for second-quarter earnings | Press release | PR Newswire | +1.47% | +2.27% | |
| ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing | Press release | PR Newswire | +0.96% | -0.89% | |
| New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents | Press release | PR Newswire | +0.20% | -0.29% | |
| Form 11-K ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form 11-K | SEC EDGAR | +0.15% | +0.09% | |
| Abbott declares 410th consecutive quarterly dividend | Press release | PR Newswire | +0.20% | +0.97% | |
| New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers | Press release | PR Newswire | -0.17% | -0.43% | |
| New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis | Press release | PR Newswire | -0.17% | -0.43% | |
| Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes | Press release | PR Newswire | +0.61% | +1.18% | |
| Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes | Press release | PR Newswire | -0.88% | -1.28% | |
| ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening | Press release | PR Newswire | -0.88% | -1.28% | |
| Form SD ABBOTT LABORATORIES | SEC filing · Form SD | SEC EDGAR | +0.61% | +1.18% | |
| Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 | Press release | PR Newswire | +0.35% | +0.66% | |
| Form 10-Q ABBOTT LABORATORIES For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.19% | -0.52% | |
| Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform | Press release | PR Newswire | +0.44% | +0.05% | |
| Form 8-K ABBOTT LABORATORIES For: Apr 24 | SEC filing · Form 8-K | SEC EDGAR | +0.44% | +0.05% | |
| Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 | Press release | PR Newswire | +1.14% | +2.11% | |
| Form S-8 ABBOTT LABORATORIES | SEC filing · Form S-8 | SEC EDGAR | +1.14% | +2.11% | |
| Form 8-K ABBOTT LABORATORIES For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | -0.42% | -0.52% | |
| New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test | Press release | PR Newswire | +0.10% | +0.11% | |
| Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences | Press release | PR Newswire | +0.34% | -1.58% | |
| Form 8-K ABBOTT LABORATORIES For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | +0.34% | -1.58% | |
| New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health | Press release | PR Newswire | -0.09% | +0.07% | |
| Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform | Press release | PR Newswire | -1.37% | -2.52% | |
| Abbott hosts conference call for first-quarter earnings | Press release | PR Newswire | +0.12% | -0.03% | |
| John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening | Press release | PR Newswire | -0.80% | +0.33% | |
| Abbott completes acquisition of Exact Sciences | Press release | PR Newswire | -0.58% | -1.35% | |
| Form 8-K ABBOTT LABORATORIES For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | -1.35% | |
| Form S-8 ABBOTT LABORATORIES | SEC filing · Form S-8 | SEC EDGAR | -0.80% | +0.33% | |
| Abbott acquisition of Exact Sciences set to close on March 23, 2026 | Press release | PR Newswire | -0.25% | -1.87% | |
| Form ARS ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.29% | +0.98% | |
| Form DEF 14A ABBOTT LABORATORIES For: Apr 24 | SEC filing · Form DEF | SEC EDGAR | +0.29% | +0.98% | |
| Form DEFA14A ABBOTT LABORATORIES | SEC filing · Form DEFA14A | SEC EDGAR | +0.29% | +0.98% | |
| Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management | Press release | PR Newswire | +0.14% | -1.49% | |
| Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team' | Press release | PR Newswire | -0.35% | -0.22% | |
| Form 8-K ABBOTT LABORATORIES For: Mar 09 | SEC filing · Form 8-K | SEC EDGAR | -0.27% | -1.27% | |
| Trial Set in NEC Multidistrict Litigation Against Reckitt Benckiser’s Mead Johnson Led by Levin Papantonio | Press release | Business Wire | +0.13% | -0.47% | |
| Form 8-K ABBOTT LABORATORIES For: Feb 23 | SEC filing · Form 8-K | SEC EDGAR | -0.13% | +0.19% | |
| Form S-3ASR ABBOTT LABORATORIES | SEC filing · Form S-3ASR | SEC EDGAR | +0.59% | +2.81% | |
| Abbott declares 409th consecutive quarterly dividend | Press release | PR Newswire | +0.04% | +0.23% | |
| Form 10-K ABBOTT LABORATORIES For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.59% | +2.81% | |
| Form 8-K ABBOTT LABORATORIES For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.59% | +2.81% | |
| Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation | Press release | PR Newswire | -0.18% | +0.71% | |
| Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook | Press release | PR Newswire | +2.06% | +0.56% | |
| Form 8-K ABBOTT LABORATORIES For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | +2.06% | +0.56% | |
| Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms | Press release | PR Newswire | -0.47% | -0.11% | |
| Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada | Press release | Canada Newswire | -0.80% | -0.98% | |
| Abbott hosts conference call for fourth-quarter earnings | Press release | PR Newswire | +0.77% | +0.80% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ABT section they belong to.
More of the dataset.
ABT earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.